Summary of AGT
The AGT gene encodes a protein called angiotensinogen which is part of the renin-angiotensin system. The system regulates blood pressure and the balance of fluids and salts in the body (R).
Mutations can cause problems with the kidneys and also cause excessively high or low blood pressure (R).
The Function of AGT
Angiotensin 1-7: is a ligand for the G-protein coupled receptor MAS1. Has vasodilator and antidiuretic effects. Has an antithrombotic effect that involves MAS1-mediated release of nitric oxide from platelets.
Protein names
Recommended name:
AngiotensinogenAlternative name(s):
Serpin A8Angiotensin 1-10
Angiotensin I
Ang I
Angiotensin 1-8
Angiotensin II
Ang II
Angiotensin 2-8
Angiotensin III
Ang III
Des-Asp[1]-angiotensin II
Angiotensin 3-8
Angiotensin IV
Ang IV
- RS11122576 (AGT) ??
- RS2004776 (AGT) ??
- RS2478545 (AGT) ??
- RS2493137 (AGT) ??
- RS3889728 (AGT) ??
- RS4762 (AGT) ??
- RS5050 (AGT) ??
- RS5051 (AGT) ??
- RS6687360 (AGT) ??
- RS699 (AGT) ??
- RS7079 (AGT) ??
To see your genotype, you should be logged in and have a file with your genotype uploaded.
Top Gene-Substance Interactions
AGT Interacts with These Diseases
| Disease | Score |
Substances That Increase AGT
| Substances | Interaction | Organism | Category |
Substances That Decrease AGT
| Substances | Interaction | Organism | Category |
Advanced Summary
renal tubular dysgenesis At least six mutations in the AGT gene have been found to cause a severe kidney disorder called renal tubular dysgenesis. This condition is characterized by abnormal kidney development before birth, the inability to produce urine (anuria), and severe low blood pressure (hypotension). These problems result in a reduction of amniotic fluid (oligohydramnios), which leads to a set of birth defects known as the Potter sequence. Renal tubular dysgenesis can be caused by mutations in both copies of any of the genes involved in the renin-angiotensin system. Most of the mutations in the AGT gene that cause this disorder change single protein building blocks (amino acids) in the angiotensinogen protein. These changes occur in a region of the protein that is necessary for its conversion to angiotensin I. It is thought that the altered angiotensinogen cannot be converted, leading to a nonfunctional renin-angiotensin system. Without this system, the kidneys cannot control blood pressure. Because of low blood pressure, the flow of blood is reduced (hypoperfusion), and the body does not get enough oxygen during fetal development. As a result, kidney development is impaired, leading to the features of renal tubular dysgenesis. other disorders Variations in the AGT gene are associated with susceptibility to a form of high blood pressure (hypertension) called essential hypertension. Essential hypertension is a complex disorder associated with many genetic and environmental factors. The AGT gene variations associated with this condition affect single DNA building blocks (nucleotides) and likely lead to higher levels of the angiotensinogen protein.
The AGT gene provides instructions for making a protein called angiotensinogen. This protein is part of the renin-angiotensin system, which regulates blood pressure and the balance of fluids and salts in the body. In the first step of this process, angiotensinogen is converted to angiotensin I. Through an additional step, angiotensin I is converted to angiotensin II. Angiotensin II causes blood vessels to narrow (constrict), which results in increased blood pressure. This molecule also stimulates production of the hormone aldosterone, which triggers the absorption of salt and water by the kidneys. The increased amount of fluid in the body also increases blood pressure. Proper blood pressure during fetal growth, which delivers oxygen to the developing tissues, is required for normal development of the kidneys, particularly of structures called the proximal tubules, and other tissues. In addition, angiotensin II may play a more direct role in kidney development, perhaps by affecting growth factors involved in the development of kidney structures.
Conditions with Increased Gene Activity
| Condition | Change (log2fold) | Comparison | Species | Experimental variables | Experiment name |
|---|
Conditions with Decreased Gene Activity
| Condition | Change (log2fold) | Comparison | Species | Experimental variables | Experiment name |
|---|
Technical
The following transcription factors affect gene expression:
Tissue specificity:
Expressed by the liver and secreted in plasma.
Gene Pathways:
Caution:
It is uncertain whether Met-1 or Met-10 is the initiator.
Molecular Function:
- Growth Factor Activity
- Hormone Activity
- Receptor Agonist Activity
- Serine-Type Endopeptidase Inhibitor Activity
- Sodium Channel Regulator Activity
- Superoxide-Generating Nadph Oxidase Activator Activity
- Type 1 Angiotensin Receptor Binding
- Type 2 Angiotensin Receptor Binding
Biological Processes:
- Activation Of Phospholipase C Activity
- Aging
- Angiotensin-Activated Signaling Pathway
- Angiotensin Maturation
- Angiotensin-Mediated Drinking Behavior
- Artery Smooth Muscle Contraction
- Blood Vessel Remodeling
- Catenin Import Into Nucleus
- Cell-Cell Signaling
- Cell Growth Involved In Cardiac Muscle Cell Development
- Cell Surface Receptor Signaling Pathway
- Cellular Response To Mechanical Stimulus
- Cellular Sodium Ion Homeostasis
- Cytokine Secretion
- Erk1 And Erk2 Cascade
- Female Pregnancy
- Fibroblast Proliferation
- G-Protein Coupled Receptor Signaling Pathway
- G-Protein Coupled Receptor Signaling Pathway Coupled To Cgmp Nucleotide Second Messenger
- Kidney Development
- Low-Density Lipoprotein Particle Remodeling
- Negative Regulation Of Angiogenesis
- Negative Regulation Of Cell Growth
- Negative Regulation Of Gene Expression
- Negative Regulation Of Neurotrophin Trk Receptor Signaling Pathway
- Negative Regulation Of Sodium Ion Transmembrane Transporter Activity
- Negative Regulation Of Tissue Remodeling
- Nitric Oxide Mediated Signal Transduction
- Phospholipase C-Activating G-Protein Coupled Receptor Signaling Pathway
- Positive Regulation Of Activation Of Jak2 Kinase Activity
- Positive Regulation Of Blood Pressure
- Positive Regulation Of Branching Involved In Ureteric Bud Morphogenesis
- Positive Regulation Of Cardiac Muscle Cell Apoptotic Process
- Positive Regulation Of Cardiac Muscle Hypertrophy
- Positive Regulation Of Cellular Protein Metabolic Process
- Positive Regulation Of Cholesterol Esterification
- Positive Regulation Of Cytokine Production
- Positive Regulation Of Cytosolic Calcium Ion Concentration
- Positive Regulation Of Endothelial Cell Migration
- Positive Regulation Of Epidermal Growth Factor Receptor Signaling Pathway
- Positive Regulation Of Extracellular Matrix Constituent Secretion
- Positive Regulation Of Extrinsic Apoptotic Signaling Pathway
- Positive Regulation Of Fibroblast Proliferation
- Positive Regulation Of Gap Junction Assembly
- Positive Regulation Of Glucose Import In Response To Insulin Stimulus
- Positive Regulation Of Inflammatory Response
- Positive Regulation Of L-Arginine Import Into Cell
- Positive Regulation Of L-Lysine Import Into Cell
- Positive Regulation Of Macrophage Derived Foam Cell Differentiation
- Positive Regulation Of Membrane Hyperpolarization
- Positive Regulation Of Nad(P)H Oxidase Activity
- Positive Regulation Of Nf-Kappab Transcription Factor Activity
- Positive Regulation Of Nitric Oxide Biosynthetic Process
- Positive Regulation Of Peptidyl-Tyrosine Phosphorylation
- Positive Regulation Of Phosphatidylinositol 3-Kinase Signaling
- Positive Regulation Of Protein Tyrosine Kinase Activity
- Positive Regulation Of Reactive Oxygen Species Metabolic Process
- Positive Regulation Of Renal Sodium Excretion
- Positive Regulation Of Superoxide Anion Generation
- Positive Regulation Of Transcription, Dna-Templated
- Positive Regulation Of Vascular Associated Smooth Muscle Cell Migration
- Positive Regulation Of Vascular Smooth Muscle Cell Proliferation
- Positive Regulation Of Vasodilation
- Regulation Of Blood Pressure
- Regulation Of Blood Vessel Diameter By Renin-Angiotensin
- Regulation Of Blood Volume By Renin-Angiotensin
- Regulation Of Calcium Ion Transport
- Regulation Of Cardiac Conduction
- Regulation Of Cell Growth
- Regulation Of Cell Proliferation
- Regulation Of Extracellular Matrix Assembly
- Regulation Of Heart Rate
- Regulation Of Long-Term Neuronal Synaptic Plasticity
- Regulation Of Norepinephrine Secretion
- Regulation Of Renal Output By Angiotensin
- Regulation Of Renal Sodium Excretion
- Regulation Of Transmission Of Nerve Impulse
- Regulation Of Vasoconstriction
- Renal System Process
- Renin-Angiotensin Regulation Of Aldosterone Production
- Response To Muscle Activity Involved In Regulation Of Muscle Adaptation
- Smooth Muscle Cell Proliferation
- Stress-Activated Mapk Cascade
- Uterine Smooth Muscle Contraction
- Vasodilation